Drug Interaction-induced Hemolytic Anemia: An Unresolved Diagnostic Process
Author:
Affiliation:
1. Oncology Center, Aichi Medical University Hospital, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_2119-23/_pdf
Reference7 articles.
1. 1. Smith SM, Wachter K, Burris HA 3rd, et al. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. J Clin Oncol 39: 1165-1184, 2021.
2. 2. Alkan A, Yasar A, Karci E, et al. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 25: 229-236, 2017.
3. 3. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 24: 143-150, 2010.
4. 4. Isomura Y, Tamiya H. Alectinib-induced hemolytic anemia with positive direct antiglobulin test in a patient with lung adenocarcinoma: a possible drug-drug interaction effect. Intern Med, (in press).
5. 5. Gullapalli V, Xu W, Lewis CR, Anazodo A, Gerber GK. A multi-centre case series of alectinib-related erythrocyte membrane changes and associated haemolysis. J Hematop 14: 131-136, 2021.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3